Supra-ampullar cystectomy with preservation of sexual function and ileal orthotopic reservoir for bladder tumor: Twenty years of experience

European Urology

Volumn 46, Issue 2, 2004, Pages 264-270

  Terrone, Carlo ^a   Cracco, Cecilia ^a   Scarpa, Roberto Mario ^a   Rossetti, Salvatore Rocca ^a  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Bladder carcinoma; Bladder substitution; Cystectomy; Impotence

Indexed keywords

BCG VACCINE; CISPLATIN; DOXORUBICIN; METHOTREXATE; MITOMYCIN C; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; CYSTECTOMY; EJACULATORY DUCT; ENDOSCOPIC BIOPSY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMITTENT CATHETERIZATION; LEIOMYOSARCOMA; LYMPH NODE; MALE; METASTASIS; MICTURITION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEMINAL VESICLE; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SURGICAL TECHNIQUE; TRANSITIONAL CELL CARCINOMA; URETHRA; URINE INCONTINENCE; VAS DEFERENS;

EID: 3142611085     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.03.006     Document Type: Article

References (33)

1. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur. Urol. 41:2002;105
2. Walsh P.C., Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol. 128:1982;492
3. Walsh P.C., Mostwin J.L. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br. J. Urol. 56:1984;694
4. Rocca Rossetti S., Randone D.F., Vestita E., Aveta P., Terrone C., Neira D., et al. Cystectomy: indications and technique. Oncology. Munchen, Sympomed. 3:1994;106
5. Lilien O.M., Camey M. 25-year experience with replacement of the human bladder (Camey procedure). J. Urol. 132:1984;886
6. Camey M., Botto H. The ileal neobladder: development and long-term experience, Camey I and II. Scand J. Urol. Nephrol. Suppl. 142:1992;98
7. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 6th edn. New York: Wilely-Liss; 2002.
8. Rocca Rossetti S., Terrone C., Cracco C., Ceratti G., Carone R. Ileal Orthotopic neobladder: our experience. Acta Urol. Ital. 2:1996;65
9. Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate. 4:1983;473
10. Schlegel P.N., Walsh P.C. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J. Urol. 138:1987;1402
11. Schoenberg M.P., Walsh P.C., Breazeale D.R., Marshall F.F., Mostwin J.L., Brendler C.B. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J. Urol. 155:1996;490
12. Venn S.N., Popert R.M., Mundy A.R. "Nerve sparing" cystectomy and substitution cystoplasty in patients of either sex: limitations and techniques. Br. J. Urol. 82:1998;361
13. Schilling A., Friesen A. Transprostatic selective cystectomy with an ileal bladder. Eur. Urol. 18:1990;253
14. Spitz A., Stein J.P., Lieskovsky G., Skinner D.G. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J. Urol. 161:1999;1761
15. Colombo R., Bertini R., Salonia A., Da Pozzo L.F., Montorsi F., Brausi M., et al. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J. Urol. 165:2001;51
16. Horenblas S., Meinhardt W., Ijzerman W., Moonen L.F. Sexuality preserving cystectomy and neobladder: initial results. J. Urol. 166:2001;837
17. Vallancien G., Abou El Fettouh H., Cathelineau X., Baumert H., Fromont G., Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J. Urol. 68:2002;2413
18. Turner W.H., Danuser H., Moehrle K., et al. The effect of nerve sparing cystectomy technique on postoperative continence after orthotopic bladder substitution. J. Urol. 158:1997;2118
19. Catalona W.J., Carvalhal G.F., Mager D.E., Smith D.S. Potency, continence and complication rates in 1, 870 consecutive radical retropubic prostatectomies. J. Urol. 162:1999;433
20. Hautmann R.E., Miller K., Steiner U., et al. The ileal neobladder: 6 years of experience with more than 200 patients. J. Urol. 150:1993;40
21. Madersbacher S., Möhrle K., Burkhard F., Studer U.E. Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J. Urol. 167:2002;2052
22. Steers W.D. Voiding dysfunction in the orthotopic neobladder. World J. Urol. 18:2000;330
23. Hautmann R.E. Urinary diversion: ileal conduit to neobladder. J. Urol. 169:2003;834
24. Kabalin J.N., McNeal J.E., Price H.M., Freiha F.S., Stamey T.A. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J. Urol. 141:1989;1091
25. Brawn P.N., Kuhl D., Speights V.O., Johnson C.F. III, Lind M. The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma. Arch. Pathol. Lab. Med. 119:1995;731
26. Ohori M., Wheeler T.M., Dunn J.K., Stamey T.A., Scardino P.T. The pathological features and prognosis of prostate cancers detectable with current diagnosis tests. J. Urol. 152:1994;1714
27. Epstein J.I., Walsh P.C., Carmichael M., Brendler C.B. Pathological and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer. JAMA. 271:1994;368
28. Lebret T., Hervé J.M., Barré P., Gaudez F., Lugagne P.M., Barbagelatta M., et al. Urethral recurrence of transitional cell carcinoma of the bladder. Eur. Urol. 33:1998;170
29. Hardeman S.W., Soloway M.S. Urethral recurrence following radical cystectomy. J Urol. 144:1990;666
30. Elmajian D.A. Indications for urethrectomy. Semin. Urol. Oncol. 19:2001;37
31. Nixon R.G., Chang S.S., Lafleur B.J., Smith J.A., Cookson M.S. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J. Urol. 167:2002;502
32. Donat S.M., Wei D.C., McGuire M.S., Herr H.W. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J. Urol. 165:2001;1580
33. Freeman J.A., Tarter T.A., Esrig D., Stein J.P., Elmajian D.A., Chen S.C., et al. Urethral recurrence in patients with orthotopic ileal neobladders. J. Urol. 156:1996;1615